<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08032472019183</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid pediatric</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472019183</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:26:12.480Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472019060</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472019060</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:26:11.478Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472013266</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472013266</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:26:01.644Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472013259</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472013259</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:26:00.468Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472013242</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472013242</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:59.245Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472013235</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472013235</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:58.050Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472013228</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472013228</reference>
    <placedOnMarketCountry>Slovenia</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:52.040Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472013211</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472013211</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:50.839Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472013204</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472013204</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:49.641Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472013198</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472013198</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:48.480Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472013181</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472013181</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:42.451Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472012658</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472012658</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:30.433Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472012597</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472012597</reference>
    <placedOnMarketCountry>Slovenia</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:29.227Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472007944</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472007944</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:20.822Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472006916</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472006916</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:19.625Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472006893</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472006893</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:13.628Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472006879</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472006879</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:12.418Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472006855</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472006855</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:11.252Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472006831</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472006831</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:10.021Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472006817</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472006817</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:25:04.006Z</lastUpdated>
  </row>
</eudamedExport>